Evaluation of Crestor® (Rosuvastatin) in Daily Practice

This open label, non-interventional study is to show the efficacy of Crestor (rosuvastatin) in reduction of LDL-cholesterol and cardiovascular risk parameters in patients with hypercholesterolemia. Effectiveness is to be evaluated using the difference in LDL cholesterol level between the first and the second visit after 12 weeks.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Hypercholesterolemia Dyslipidemias Hyperlipidemias Lipid Metabolism Disorders Metabolic Diseases Nutritional and Metabolic Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

a patient with hypercholesterolemia who has been prescribed Crestoraccording to physician's judgement, irrespective of the inclusion in the study.
no treatment with any statin in the last 3 months

Exclusion criteria

hypersensitivity to rosuvastatin or any other ingredient of Crestor
active liver disease, severe renal insufficiency
myopathy or predisposing risk factors for myopathy/ rhabdomyolysis
woman of child-bearing potential and not using appropriate contraceptive measures, pregnancy or lactation

Treatment and study plan

Primary outcomes

LDL-cholesterol reduction

Time frame: 12 weeks

Secondary outcomes

achievement of target levels of total cholesterol and LDL-cholesterol

Time frame: 12 weeks
patient compliance

Time frame: 12 weeks
change in coronary risk

Time frame: 12 weeks

Sponsors and collaborators

Lead sponsor

AstraZeneca

Industry

Registry information

Official study title

Open-Label Non-Interventional Evaluation of Efficacy of Crestor® (Rosuvastatin) in Reduction of LDL-Cholesterol and Cardiovascular Risk Parameters in Patients With Hypercholesterolaemia

Important dates

Study start: 2007
Study completion: 2007
First posted: Feb 5, 2009
Registry last updated: Feb 6, 2009

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed